Upcoming Dissertation
Tuesday 7 May, Maryam Tofiq of our Work package Pulmonary Drug Delivery defends her thesis Tableting performance of dry granulated particles
Our research program
Learn more about SweDeliver's research program with a focus on challenges in drug delivery via parenteral, oral and pulmonary administration.
Our junior researchers
Meet the many highly talented PhD students and postdocs who are at the center of our ongoing work to shape the future of drug delivery
Contact SweDeliver
Contact our board and administration
Stay updated with SweDeliver
Follow our Social Media & Newsletters
Our partners
SweDeliver's industry partners are a selection of 18 pharmaceutical and biotech companies that all contribute important scientific and industrial expertise.
Our publications
Access the latest scientific publications based on research conducted at our center contributing new knowledge in the challenges facing drug delivery.
Our alumni
Meet a selection of SweDeliver's former PhD students and postdocs who have completed their work in our center and entered the next phase of their career.
SweDeliver collaborations
Meet our partners, alumni & exam workers
SweDeliver summary
Our boards, social media & voices of SweDeliver
Welcome to SweDeliver
SweDeliver is a world leading research and competence centre in Drug Delivery. Many novel molecules in the drug discovery and development pipeline are biological compounds such as proteins, peptides and RNA. These display problems of poor solubility, membrane permeability and low bioavailability. Thus, the Drug Delivery area is today facing tremendous challenges to develop new drug therapies.
SweDeliver was established in response to these challenges. Based on a multi-disciplinary collaboration between academia and industry with financial support from Vinnova (Sweden’s Innovation Agency), the Faculty of Pharmacy at Uppsala University is the academic hub of the Centre with 18 industrial partners contributing expertise and research infrastructure as well as industrial perspectives and needs within the three main research areas of the Centre.
SweDeliver is prioritising to focus on outstanding research challenges within Parenteral, Oral and Pulmonary Drug Delivery
The research will ultimately lead to development of new and improved drug therapies with respect to both efficacy and patient safety. The Centre will also further support the strong research environment and the drug delivery ecosystem in the Nordic region.
